CASP3 and rheumatoid arthritis: To assess the contribution of caspases in celecoxib-mediated cytotoxicity, RA FLSs were treated with the pan-caspase inhibitor z-VAD-fmk or with z-DEVD-fmk, a specific inhibitor of caspase 3, and subsequently with celecoxib (60 μM).